... Alkylating agents approved to treat multiple myeloma include: Melphalan (Alkeran) Carmustine (BiCNU) Cyclophosphamide (Cytoxan) Vincristine (formerly sold as Oncovin) Melphalan flufenamide (Pepaxto) Bendamustine (Treanda) AnthracyclinesChemotherapy drugs called anthracyclines also damage DNA and prevent cells from dividing. ...
... Alkylating agents approved to treat multiple myeloma include: Melphalan (Alkeran) Carmustine (BiCNU) Cyclophosphamide (Cytoxan) Vincristine (formerly sold as Oncovin) Melphalan flufenamide (Pepaxto) Bendamustine (Treanda) AnthracyclinesChemotherapy drugs called anthracyclines also damage DNA and prevent cells from dividing. ...
... They include melphalan (Alkeran, Evolema), cyclophosphamide, carmustine (BiCNU), and bendamustine (Treanda). Anthracyclines — These treatments slow the growth of cancer cells by interfering with cell division. They include doxorubicin and doxorubicin liposome (Doxil). ...
... They include melphalan (Alkeran, Evolema), cyclophosphamide, carmustine (BiCNU), and bendamustine (Treanda). Anthracyclines — These treatments slow the growth of cancer cells by interfering with cell division. They include doxorubicin and doxorubicin liposome (Doxil). ...